Lansoprazol Flas Salvat

Lansoprazole, the active ingredient in Lansoprazol Flas Salvat, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders in adults. The medication works by targeting the stomach's acid‑secreting cells, providing relief from symptoms such as heartburn, ulcer pain, and reflux.

GNH USA supplies Lansoprazol Flas Salvat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is indicated for several acid‑related gastrointestinal conditions. - Gastroesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by lowering stomach acidity. - Peptic ulcer disease: promotes ulcer healing and reduces recurrence by suppressing acid secretion. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑producing tumors. - NSAID‑induced ulcer prophylaxis: prevents ulcer formation in patients regularly using non‑steroidal anti‑inflammatory drugs.

Lansoprazole may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain in the head. - Diarrhea: loose, watery stools. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis that may require medical treatment. - Hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Low magnesium levels (hypomagnesemia): muscle cramps, seizures, or cardiac arrhythmias.

Before prescribing Lansoprazole, certain safety considerations should be evaluated. - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Avoid long‑term use without supervision: risk of nutrient malabsorption. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Lansoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect; avoid concurrent use. - Atazanavir or other protease inhibitors: markedly decreased absorption; avoid. - Methotrexate (high dose): increased toxicity; avoid.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Digoxin: altered serum levels; monitor therapeutic range. - Diazepam: increased plasma concentration; observe for enhanced sedation.